戻る
Innate Pharma Shares Decline Amid Strategic Restructuring and H1 2025 Financial Report
戻る
株式ニュース
テーマ
Innate Pharma Shares Decline Amid Strategic Restructuring and H1 2025 Financial Report
Innate Pharma Shares Decline Amid Strategic Restructuring and H1 2025 Financial Report
Edgen Stock
·
Sep 20 2025, 07:59
共有先
共有先
リンクをコピー
ソース：
[1] Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial Resilience Amidst Challenges
[2] Innate Pharma H1 Net Loss Shrinks, Plans 30% Workforce Cut, Stock Drops | Nasdaq
[3] Innate Pharma H1 2025 slides: strategic refocus on key assets extends cash runway
Edgen Stock·Sep 20 2025, 07:59Edgen Stock·Sep 20 2025, 07:59
Edgen Stock·Sep 20 2025, 07:59